Premium
Elevated plasma cholesterol does not affect brain Aβ in mice lacking the low‐density lipoprotein receptor
Author(s) -
Elder Gregory A.,
Cho Julie Y.,
English Daniel F.,
Franciosi Sonia,
Schmeidler James,
Sosa Miguel A. Gama,
Gasperi Rita De,
Fisher Edward A.,
Mathews Paul M.,
Haroutunian Vahram,
Buxbaum Joseph D.
Publication year - 2007
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1111/j.1471-4159.2007.04614.x
Subject(s) - cholesterol , ldl receptor , endocrinology , medicine , apolipoprotein e , genetically modified mouse , receptor , lipoprotein , in vivo , biology , transgene , disease , biochemistry , microbiology and biotechnology , gene
Epidemiological studies support an association between vascular risk factors, including hypercholesterolemia, and Alzheimer’s disease (AD). Recently, there has been much interest in the possibility that hypercholesterolemia might directly promote β‐amyloid (Aβ) production. Indeed, in vitro studies have shown that increasing cellular cholesterol levels enhances Aβ production. However, studies in AD transgenic mouse models have not consistently found that elevated plasma cholesterol leads to increased Aβ production or deposition in vivo . In this study, we determined whether elevated peripheral cholesterol influences Aβ production in mice with a null mutation of the low‐density lipoprotein receptor (LDLR). We show that dramatically elevated plasma cholesterol levels, whether induced by high cholesterol, high fat, or high fat/high cholesterol diets, did not affect either levels of brain Aβ40, Aβ42, or APP, or the Aβ42/40 or APP‐CTF/APP ratios, nor substantially alter brain cholesterol levels. ApoE protein levels in brain were, however, elevated, in LDLR−/− mice by post‐transcriptional mechanisms. Collectively, these studies argue that plasma cholesterol levels do not normally regulate production of brain Aβ.